Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
All Congress filingsSearch insider filingsEarnings calendarWatchlist
MORE TOOLS
Gold IntelligenceSilver IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeAll Congress filingsSearch insider filings
More research tools
ExploreGold IntelligenceSilver IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…

CongressSearchHomeWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
LOOK INSIDE THE BUSINESS

Company financials.

Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.

View ZIVO insider activity ↗

ZIVOZivo Bioscience, Inc.

THE LATEST REPORTED YEAR

The company reported a loss.

$13.38M net loss for the year ended December 31, 2024. These are reported results, not a forecast or a stock recommendation.

Revenue$157.22KYear ended December 31, 2024
Profit or loss-$13.38MYear ended December 31, 2024
Cash from the business-$4.31MYear ended December 31, 2024
Total assets$559.45KAs of September 30, 2025
Total liabilities$3.85MAs of September 30, 2025
Cash & equivalents$1.8MAs of December 31, 2022
THE BUSINESS BEHIND THE TICKER

Revenue, over time.

Latest-filed standard financial facts · USD

$0
2022-12
$27.65K
2023-12
$157.22K
2024-12

Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.

From the filing

Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.

Reported periodReported valueFiledSource
January 1, 2024 – December 31, 2024$157,220March 18, 202510-K ↗
January 1, 2023 – December 31, 2023$27,650March 18, 202510-K ↗
January 1, 2022 – December 31, 2022$0March 15, 202410-K ↗
Source and calculation details

One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.

Concept: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · Retrieved October 15, 2026

Response SHA-256: a67c6f73387834b08f1985c02ad3ba915b8082582e19652219d78b25a60d946c

SEC company facts

Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.